How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test reveals predispositions in key GLP-1 and peptide response pathways, including variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)
The 24% Breakthrough: In Phase 2 trials, Retatrutide showed a mean weight reduction of 24.2% at the highest dose, the highest percentage ever recorded for a weight-loss drug in this timeframe. Liver Health Bonus: Research indicates that Retatrutide is exceptionally effective at clearing fat from the liver, showing over 80% reduction in liver fat for many patients
Gut microbiota mediates the protective effects of -hydroxybutyrate against cisplatin-induced acute kidney injury
Wait until you are at least 4-6 weeks into treatment and have stabilized your nutrition before beginning a new resistance training program
Circulating GLP-1 exists only at low picomolar concentrations, is rapidly inactivated by DPP-4 enzymes and is swiftly cleared by the kidneys (Hansen et al., 1999